Table 1.

Participant characteristics

YW (n = 18)PMW (n = 16)
Age, yr22 ± 156 ± 1*
Height, cm (range)163 ± 2 (142–182) 162 ± 2 (140–172)
Mass, kg (range)60 ± 2 (46–72)63 ± 2 (45–78)
BMI, kg/m2 (range)23 ± 1 (17–28)24 ± 1 (19–29)
Systolic BP, mmHg109 ± 3123 ± 3*
Diastolic BP, mmHg67 ± 280 ± 2*
Mean arterial BP, mmHg81 ± 294 ± 2*
Heart rate, beats/min60 ± 257 ± 2
Total cholesterol, mg/dl163 ± 6216 ± 7*
HDL cholesterol, mg/dl67 ± 385 ± 4*
LDL cholesterol, mg/dl82 ± 6117 ± 6*
Triglycerides, mg/dl79 ± 973 ± 7
Chol-to-HDL-C ratio2.6 ± 0.22.6 ± 0.1
Fasting plasma glucose, mg/dl80 ± 289 ± 3*
Serum [E2], pg/ml31.8 ± 19.822.0 ± 14.0
Serum [P4], ng/ml0.76 ± 0.590.67 ± 0.57
Plasma [ET-1], pg/ml1.39 ± 0.411.74 ± 0.42*
  • Values are means ± SE; n = 18 young women (YW) and 16 postmenopausal women (PMW) except for estradiol (E2), progesterone (P4), and endothelin-1 (ET-1) where n = 17 YW and 15 PMW. BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Chol, cholesterol; HDL-C, HDL-cholesterol; [E2], [P4], and [ET-1], E2, P4, and ET-1 concentration, respectively.

  • * P < 0.05 vs. YW for serum [E2], [P4], and plasma [ET-1], YW n = 17, PMW n = 15.